What role does TCF7L2 play in Blutzucker?

TCF7L2 (transcription factor 7-like 2) is one of the strongest genetic risk factors for type 2 diabetes. It primarily affects blood sugar regulation by impairing insulin secretion from pancreatic beta cells. Risk variants (e.g., rs7903146) are consistently associated with reduced insulin release and impaired glucose tolerance across many populations. The effect size is moderate but robust. However, TCF7L2 variants explain only a small fraction of individual diabetes risk; lifestyle factors such as diet, physical activity, and body weight have a much larger impact. A DNA test for TCF7L2 alone is not sufficient for diabetes diagnosis or treatment decisions. Evidence is based on large GWAS and functional studies, but clinical translation remains limited. If risk is elevated, regular blood glucose monitoring under medical supervision is recommended.